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Abstract
Dysregulation of tight junctions (TJs) is often associated with human diseases including carcinogenesis and recent studies
support role of TJ integral proteins in the regulation of Epithelial-to-Mesenchymal Transition (EMT). In this regard,
expression of claudin-1, a key constituent of TJs, is highly increased in colon cancer and is causally associated with the
tumor growth and progression. However, mechanism/s underlying regulation of claudin-1 expression in intestinal epithelial
cells remains poorly understood. In our studies, we have identified putative binding sites for intestinal transcription factors
Cdx1, -2 and GATA4 in the 59-flanking region of the claudin-1 gene. Our further studies using full length and/or deletion
mutant constructs in two different human colon cancer cell lines, SW480 and HCT116, showed key role of Cdx1, Cdx2 and
GATA4 in the regulation of claudin-1 mRNA expression. However, overexpression of Cdx2 had the most potent effect upon
claudin-1 mRNA expression and promoter activity. Also, in colon cancer patient samples, we observed a significant and
parallel correlation between claudin-1 and Cdx2 expressions. Chromatin immunoprecipitation (ChIP) assay confirmed the
Cdx2 binding with claudin-1 promoter in vivo. Using Cdx2 deletion mutant constructs, we further mapped the Cdx2 C-
terminus domain to be important in the regulation of claudin-1 promoter activity. Interestingly, co-expression of activated
b-catenin further induced the Cdx2-dependent upregulation of claudin-1 promoter activity while expression of the
dominant negative (dn)-TCF-4 abrogated this activation. Taken together, we conclude that homeodomain transcription
factors Cdx1, Cdx2 and GATA4 regulate claudin-1 gene expression in human colon cancer cells. Moreover, a functional
crosstalk between Wnt-signaling and transcriptional activation related to caudal-related homeobox (Cdx) proteins and
GATA-proteins is demonstrated in the regulation of claudin-1 promoter-activation.
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Introduction
Tight junctions (TJs), the most apical cell-cell adhesion, help
regulate the polarity and differentiated state of the epithelial cells.
Disruption of cell-cell junctions along with concomitant changes in
the expression of associated proteins helps induce invasion and
metastatic progression in cancer. The claudin family of proteins is
integral to the structure and function of tight junctions, and altered
expression of claudin family members; although in a tissue specific
manner, has been detected in multiple cancers. Several lines of
evidence suggest that claudin-1 is a key constituent of TJs [1,2],
and is directly involved in the barrier and fence functions of TJs
[3,4]. Further, studies including ours have demonstrated that
claudin-1 expression is dysregulated in a variety of cancers
including colorectal cancer [3,5]. We have further shown using a
large cohort of colon cancer patients that claudin-1 mRNA
expression is also highly increased in colon cancer [25]. It is
further worthy here to note that in colon cancer, dysregulated
claudin-1 expression associates with the tumor progression and
metastasis [5]. Also, claudin-1 is a target of b-catenin/Tcf
signaling, a key regulator of colonic homeostasis and neoplastic
growth/progression [6]. However, details of the transcriptional
regulation of colonic claudin-1 expression are not clearly
understood.
The homeodomain proteins Cdx1 and Cdx2 are the members
of the caudal-related homeobox gene family [7–9]. Studies support
the role of Cdx1 and Cdx2 in the regulation of early differentiation
and maintenance of intestinal epithelial cells. Studies using
epithelial cells of intestinal origin have demonstrated that
modulation of the expression of Cdx1 and/or Cdx2 has significant
functional effects on intestinal differentiation [10,11], proliferation
[10,12], and intestine-specific gene transcription program [13–16].
It should be noted that Cdx1 and Cdx2 bind to several intestine-
specific promoters to regulate intestine-specific gene transcription
[13–15,17,18]. Also, GATA4, a zinc finger transcription factor, is
involved in the regulation of proliferation and differentiation of
intestinal epithelial cells and helps regulate embryonic develop-
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e37174Transcriptional Regulation of Claudin-1 Expression
PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e37174ment of the gastrointestinal tract [19]. Studies have further
demonstrated that interactions of GATA4 with Cdx2 and HNF-
1a help regulate expression of several cell-cell adhesion genes
including E-cadherin and claudin-2 [19,20].
In this report, we demonstrated that colonic claudin-1 gene
expression is also a target of the transcriptional regulation by
Cdx1, Cdx2 and GATA4 where Cdx2 appeared to have most
potent effect as an inducer of colonic claudin-1 expression. We
further provide data supporting parallel correlation between
claudin-1 and Cdx2 expression in colon cancer patient samples.
Most importantly, our data suggested that Cdx2 regulates claudin-
1 expression in co-operation with Wnt-signaling, a known
regulator of claudin-1 expression.
Results
Forced Expression of Cdx1, Cdx2 or GATA4 Induces
Claudin-1 Expression in Colon Cancer Cells
To examine whether Cdx1, Cdx2 and/or GATA4 help regulate
colonic claudin-1 expression, we determined the effect of over-
expression of above transcription factors upon endogenous
claudin-1 expression. For this purpose, we used SW480 colon
cancer cells, which express low levels of endogenous claudin-1 [5].
Mammalian expression plasmid constructs containing full-length
Cdx1, Cdx2 or GATA4 were transiently transfected in SW480
cells. Empty expression plasmids served as control. Forty-eight
hours post-transfection, samples were collected and were subjected
to the preparation of lysate or total RNA extract. Immunoblotting
using antigen-specific antibody was done to confirm overexpres-
sion and similar levels of overexpression of antigens under study
(Figure 1A). As shown in Figure 1B, we observed robust
upregulation of claudin-1 in cells overexpressing Cdx1 (3.8
fold60.451), Cdx2 (6.5 fold60.854) or GATA4 (3.3 fold60.115)
at protein level. Quantitative RT-PCR showed similar induction
of claudin-1 mRNA expression upon overexpression of all the
above transcription factors and once again this induction was
maximum in cells over-expressing Cdx2 (Figure 1C). This effect of
Cdx1, Cdx2 or GATA4 upon claudin-1 expression was specific
because expression of claudin-4, yet another claudin family
member, was not affected by the forced expression of any of the
above transcription factors (Figure 1A & B).
Cdx1, Cdx2 and GATA4 Regulate Claudin-1 Gene
Transcription in Colon Cancer Cells
In above studies, forced expression of Cdx1, Cdx2 or GATA4
resulted in an increase in claudin-1 protein and mRNA
expressions. Therefore, we further determined whether Cdx1,
Cdx2 and/or GATA4 help regulate claudin-1 transcription. In
this regard, we performed luciferase reporter assay using a human
claudin-1 promoter (–1160/+160)–luciferase reporter construct
described before [21] referred as pGL3/21.2Cld-1 (Figure 2A)
throughout the manuscript. The -1160 to +160 bp region of
human claudin-1 promoter contains putative Cdx, HNF and
GATA binding sites along with the putative binding sites for
TCF/Lef-1 (Figure 2A). SW480 cells were transiently transfected
with the pGL3/21.2Cld-1 or pGL3-basic (vector alone) along
with a reference reporter plasmid. The luciferase activity of
pGL3/21.2Cld-1 was normalized to that of pGL3-basic in
addition to the reference vector. Ectopic expression of Cdx1 or
GATA4 did not alter the expression level of Cdx2, nor did Cdx2
overexpression have a noticeable effect upon Cdx1 or GATA4
protein expressions (Figure 1A). Over-expression of either Cdx1 or
GATA4 resulted in a ,3-fold increase in the promoter activity of
pGL3/21.2Cld-1. However, similar over-expression of Cdx2
resulted in a 6-fold increase in the activity of the same construct
(Figure 2B). We observed a similar trend of induction of pGL3/
21.2Cld-1-driven luciferase activity in HCT116 colon cancer,
which was 2.5–3 fold upon overexpression of Cdx1 and GATA4
and ,4-fold upon overexpression of Cdx2 (Figure 2C). We
obtained similar outcome using a longer 3.3 Kb (-3140 to +160)
claudin-1 promoter reporter assay, which was not significantly
different compared to the 1.2 Kb claudin-1 promoter (Figure S1).
Therefore, we continued the use of the 1.2 Kb claudin-1 promoter
for further studies. Our further studies supported specificity of our
above findings as over-expression of yet another transcription
factor HNF-1a did not affect claudin-1 promoter activity in either
SW480 cells (Figure S2). We further confirmed specificity of our
findings to the colonic claudin-1 expression as similar transient
overexpression of Cdx1, Cdx2 or GATA4 in human breast cancer
cells (MCF-7) or renal epithelial cells (MDCK II cells) did not
increase claudin-1 promoter activity (Figure 2D & E).
Cdx1, Cdx2 and GATA4 transcription factors work synergis-
tically to regulate expression of different genes [19]. Therefore, we
determined whether a similar synergism existed amongst Cdx1,
Cdx2 and GATA4 in the regulation of claudin-1 gene transcrip-
tion. To test, we co-transfected Cdx1 with Cdx2, Cdx1 with
GATA4 and Cdx2 with GATA4 in SW480 cells. Indeed, co-
expression of Cdx1 with Cdx2, Cdx1 with GATA4 or Cdx2 with
GATA4, all resulted in significant increase (9–13 fold) in claudin-1
promoter activity (Figure 3A). This synergism in the regulation of
claudin-1 expression was further confirmed at the protein levels
where claudin-1 expression was induced (8–10 fold) as compared
to (3–6 fold) with Cdx1, Cdx2 or GATA4 alone (Figure 3B & C).
Claudin-1 Promoter Contains Binding Sites for Cdx and
GATA Transcription Factors
Based upon our above findings, we further examined putative
binding sites for Cdx1, Cdx2 and GATA4 in claudin-1 promoter.
We used computational analysis using MatInspector software
(Oxford Molecular Group) to identify the putative binding sites for
consensus Cdx- and GATA-binding elements (Figure 2A). To
confirm the functional efficacy of these putative binding sites and
also to identify the regions involved in the regulation of claudin-1
gene transcription, we generated claudin-1 promoter deletion
constructs starting from the 59-flanking region as described
previously [21]. Figure 4A depicts the full length promoter
construct (-1160/+160) and nine deletion constructs (2850/+160,
2740/+160, 2665/+160, 2550/+160, 2490/+160, 2420/
Figure 1. Effect of Cdx1, Cdx2 and GATA4 upon endogenous claudin-1 protein and mRNA expression in SW480 colon cancer cells.
A. Western blot analysis of Cdx1, Cdx2, GATA4, claudin-1 and claudin-4 protein expression in SW480 cells. SW480 cells were transiently transfected
with Cdx1, Cdx2 and/or GATA4 expression vectors, and 20 mg of whole cell extracts were analyzed. b-actin was used as loading control. B.
Densitometry for claudin-1 and claudin-4 expression. C. Quantitative Real-Time PCR analysis. SW480 cells were co-transfected with Cdx1, Cdx2 and
GATA4 expression vectors in the presence of the indicated reporter constructs, and quantitative RT-PCR was performed. Forty eight hours later, total
RNA was isolated and subjected to real-time PCR using gene specific primers. Results were plotted as mean 6 SD from three independent
experiments and presented as fold change. *p,0.05, **p,0.01, ***p,0.001 when compared with control. Differences between two groups were
analyzed by the two-tailed Student’s t-test and of more than two groups by one-way ANOVA with post-hoc Bonferroni Multiple Comparison test.
doi:10.1371/journal.pone.0037174.g001
Transcriptional Regulation of Claudin-1 Expression
PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e37174Figure 2. A. Sequence analysis of the 59-flanking region of the human claudin-1 gene. The sequence of claudin-1 promoter and
identification of the transcription-initiation site has previously been described [21]. Putative major consensus binding sites are underlined. B. Cdx1,
Cdx2 and GATA4 regulation of claudin-1 luciferase reporter gene. SW480 (B), HCT116 (C), MCF-7 (D) and MDCK (E) cells were transiently transfected
with a 1.2-kb claudin-1-luciferase reporter plasmid along with Cdx1, Cdx2 and/or GATA4 expression vectors. Empty pGL3-basic vector was used for
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generated above were then co-transfected with Cdx1, Cdx2 or
GATA4 expression constructs into SW480 and HCT116 cells.
The full-length promoter construct contained the consensus
binding sites for Cdx and GATA4, along with the binding site
for Tcf/Lef-1, and induced claudin-1 promoter activity 5–6 fold in
SW480 cells (Figure 4B). However, this induction was lost upon
deletion of the proximal 310 bp (21160 to 2850), which
suggested that this 310 bp region has sites important for claudin-
1 promoter induction by transcription factors under investigation.
Similar findings from HCT116 cells supported this notion
(Figure 4C). Both cell lines exhibited similar patterns of promoter
activity although signals in general were stronger in SW480 cells.
This 310 bp region contained a Cdx, two GATA consensus
binding sites and a Tcf/Lef-1 binding site suggesting potential
importance of these sites in the regulation of claudin-1 gene
expression.
The C-terminal Domain is Required for Cdx2 Mediated
Activation of Claudin-1 Transcriptional Activity
Above studies suggested a role of Cdx1, Cdx2 and GATA4 in
the regulation of claudin-1 promoter. However, Cdx2 appeared to
have the most potent effect upon claudin-1 promoter activity.
Therefore, in further studies, we determined the Cdx2 domain
that is required for the transcriptional activation of claudin-1
promoter. In this regard, we tested the effect of Cdx2 deletion
mutant constructs for their ability to induce claudin-1 promoter
activity (Figure 5A) [22]. Immunoblot analysis using anti-flag
antibody confirmed similar expression levels of Cdx2 deletion
mutant constructs (Figure 5C). Results showed that deletion of the
canonical transcription activation domain (Cdx2 d55–136), the N-
terminal domains (Cdx2 d15 or Cdx2 d50) or the region between
amino acids 140 and 180 (Cdx2 d140–180) had no significant
effect on claudin-1 promoter activity. In contrast, deletion of the
Cdx2 C-terminus 244–311 (Cdx2CD) reduced claudin-1 promoter
activity by 5-fold compared to wild type Cdx2 (Figure 5B). Taken
together, these studies suggest that Cdx2 C-terminus domain is
required for the Cdx2-dependent induction of claudin-1 promoter
activation.
To further determine if Cdx2 binds to the claudin-1 promoter in
vivo, we performed ChIP analysis and compared SW480 cells
overexpressing Cdx2 with SW480 cells transfected with the empty
expression plasmid vector. The Figure 5D shows the resulting
DNA pulled down by anti-Cdx2 antibody containing the sequence
flanking the Cdx binding site. This suggested that Cdx2 binds to
the Cdx-sequence elements within the 310 bp of claudin-1
promoter and this binding increases upon overexpression of
Cdx2 in SW480 cells, which, in turn, increases claudin-1 promoter
activity. To further determine if C-terminal is important for Cdx2
binding to claudin-1 promoter, we over-expressed Cdx2CD (C-
terminal deletion mutant) or an N- terminal deletion mutant that
does not affect the claudin-1 transcriptional activity (Cdx2 d50) in
SW480 cells and performed ChIP analysis. The ChIP analysis
demonstrated that the increased binding due to full-length Cdx2
overexpression was abrogated upon overexpression of Cdx2CD
but not the N-terminal deletion (Cdx2 d50) mutant (Figure 5D).
These findings suggested that Cdx2 C-terminal domain is
important for the binding of Cdx2 to claudin-1 promoter and
Cdx2-dependent induction of claudin-1 promoter activity.
A Functional Crosstalk of Wnt Signaling and Cdx-related
Transcriptional Activation Regulates Claudin-1 Promoter
Activity
Claudin-1 is a known target of Tcf/Lef-1 signaling [6] and Tcf/
Lef-1 elements are present within the 21160 to 2850 region of
claudin-1 promoter. To test the effect of b-catenin/Tcf/Lef-1,
claudin-1 promoter was subjected to co-transfection in presence or
absence of activated b-catenin (S33Y) along with Cdx1, 2 or
GATA4. Transient transfections were done in SW480 and
HCT116 cells and luciferase activity of pGL3/21.2Cld-1 was
normalized to pGL3-Basic in addition to the reference vector.
Overexpression of activated b-catenin (S33Y) with Cdx1, Cdx2 or
GATA4 resulted in atleast two fold further induction of claudin-1
promoter-mediated gene expression compared to Cdx1, Cdx2 or
GATA4 alone (Figure 6A &B). Conversely, when we over-
expressed Cdx1, Cdx2 or GATA4 with dnTcf-4, the induction of
claudin-1 promoter was abrogated suggesting potential cross talk
between these factors (Figure 6C &D). Taken together, our data
suggested that modulation of b-catenin/Tcf/Lef activity plays
central role in the Cdx, GATA4 mediated regulation of claudin-1
expression.
Claudin-1 and Cdx2 Expressions are Correlated in Human
Colorectal Carcinoma Samples
Cdx2 protein expression is associated with advanced stages of
colon tumorigenesis [23]. Claudin-1 expression positively corre-
lates with tumor progression and metastasis in colon cancer [5].
Therefore, we investigated a possible correlation between Cdx2
and claudin-1 expressions in colon cancer. We examined the
potential correlation between claudin-1 and Cdx2 expressions in a
large population of human tissue samples. Immunohistochemical
analysis for claudin-1 and Cdx2 in custom colorectal cancer tissue
arrays (tissue microarrays developed at Vanderbilt University by
Dr. M.K. Washington; which contain surgical specimens from 50
primary and paired metastatic fresh frozen human colorectal
cancer sample) was performed. Results showed predominant
nuclear immunostaining for Cdx2 while claudin-1 staining was
predominantly cytosolic though some punctate membrane staining
was also observed (Figure 7B). Importantly, further analysis
demonstrated a significant correlation (p,0.01) between claudin-
1 and Cdx2 expressions in 36:50 (72%) colon cancer samples
(Fig. 7A). Taken together, these data suggest a direct correlation
between the expressions of Cdx2 and claudin-1 in colorectal
carcinomas.
Discussion
Dysregulation of colonocyte differentiation lies at the core of
colon carcinogenesis. Claudin-1 expression is highly increased in
colon cancer and is causally associated with the tumor growth and
progression [5]. Of interest, in addition to the dysregulated protein
expression and localization, claudin-1 mRNA expression also
control purposes. Nonspecific plasmid DNA was used to maintain equal amounts of DNA in all transfection samples. Results are expressed in fold-
activation of relative luciferase activity after normalization with Renilla activity from 3 independent experiments, and the values are expressed as
means 6 SD. *p,0.05, **p,0.01, ***p,0.001 when compared with control. Differences between two groups were analyzed by the two-tailed
Student’s t-test and of more than two groups by one-way ANOVA with post-hoc Bonferroni Multiple Comparison test.
doi:10.1371/journal.pone.0037174.g002
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e37174Figure 3. A. Synergistic effect of Cdx1, Cdx2 and GATA4 overexpression upon claudin-1 protein expression and gene transcription.
SW480 cells were co-transfected with different combinations of Cdx1, Cdx2 and GATA4 expression vectors in the presence of indicated reporter
constructs, and luciferase assays were performed. Forty eight hours later, cells were lysed and luciferase activity was measured. Results were plotted
as mean 6 SD from three independent experiments and normalized luciferase activity in each cell line was presented as relative luciferase activity.
The mean value of cells transfected with pGL3-basic vector in the absence of expression vectors was set to 1. B and C. Western blot analysis of
claudin-1 protein expression in SW480 cells. SW480 cells were transfected with different combinations of Cdx1, Cdx2 and GATA4 expression vectors
and 20 mg of proteins were analyzed. **p,0.01, ***p,0.001, ****p,0.0001 when compared with control. Differences between two groups were
analyzed by the two-tailed Student’s t-test and of more than two groups by one-way ANOVA with post-hoc Bonferroni Multiple Comparison test.
doi:10.1371/journal.pone.0037174.g003
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manipulation of claudin-1 expression in colon cancer cells resulted
in sharp and inverse changes in their differentiation status
including E-cadherin expression [5,24]. Also, induction of
epithelial differentiation in colon cancer cells using Histone
deacetylase (HDAC) inhibitors associated with a specific decrease
in claudin-1 expression among claudin family members [25].
Taken together, claudin-1 expression appears to affect colon
carcinogenesis through the modulation of colonic epithelial cell
differentiation. Therefore, we examined the role of transcription
factors important in the regulation of intestinal epithelial
differentiation as well as colon carcinogenesis in the regulation
of claudin-1 mRNA transcription. The key outcome of our studies
using two different and widely used colon cancer cell lines were (i)
Cdx1, Cdx2 and GATA4 help regulate claudin-1 gene transcrip-
tion and this regulation was specific to the cells of colonic origin,
(ii) Cdx2 is the most potent inducer of claudin-1 promoter activity
amongst Cdx1, Cdx2 and GATA4, and physically binds to the
Cdx-consensus binding site/s in claudin-1 promoter, as deter-
mined by the ChIP analysis, (iii) Cdx1, Cdx2 and GATA4 regulate
colonic claudin-1 expression through potential synergism among
each-other and through the potential cross-talk with the Wnt-
signaling pathway. Taken together, in this report we provide the
first insights into the complex transcriptional activation events,
which regulate colonic claudin-1 expression.
The caudal homeobox protein Cdx1 is expressed mainly in the
crypt compartment, whereas the Cdx2 protein is detected in both
the crypt and the villus compartments [26]. Importantly, outcome
from multiple studies suggest that the role of Cdx1 and Cdx2 in
the regulation of intestinal homeostasis is often complementary
and may depend upon the maturation of the intestinal epithelial
cells [27]. These findings are complemented with the demonstra-
tion of a rather discrete role of Cdx1 in the regulation of intestinal
epithelial cell proliferation, while Cdx2 play important role in the
regulation of the differentiation status of the intestinal epithelial
cells [28]. GATA4 also belongs to a family of transcription factors
that play important role in the regulation of embryogenesis and
possibly early maturation of intestinal epithelial cells [29]. GATA4
along with GATA5/6 has been associated with cell survival, cell
proliferation, and neoplastic transformation of various cell types
[8–15]. Notably, among gastrointestinal cancers, GATA4 is
amplified in ,10% of esophageal adenocarcinomas and Barrett
metaplasia [30]. Role of GATA4 in the regulation of colon
carcinogenesis is not well studied though limited studies suggested
that it may function as a tumor suppressor in the colon cancer
[31]. However, one need to be cautioned in the specific functional
formulation of such transcription factors as their function/s are
often context dependent and interaction with other transcriptional
regulators are also important.
Of interest, role of Cdx2 transcription factor in the regulation of
coloncarcinogenesisremaincontroversialandstudiessuggestitsrole
asapositiveornegative‘tumormodulator’.Inthisregard,micethat
are heterozygous-null for Cdx2 gene develop colonic hamartomas
after the remaining Cdx2 allele is lost [32,33]. These heterozygous-
null Cdx2 mice are also sensitive to the azoxymethane (AOM)-
induced colonic adenocarcinoma [34]. Also, the compound hetero-
zygotes for Cdx2 and Adenomatous Polyposis Coli (Apc) genes
develop more adenomatous polyps in the colon compared to their
heterozygous Apc littermates [35]. Together, above findings would
suggest function of Cdx2 as a colon tumor suppressor. However,
immunohistochemicalanalysishasdetectedstrongCdx2expression
in,90%ofthehumancoloncancersamples[38,39].Further,Cdx2-
overexpressionincoloncancercellsinducesanchorage-independent
growthandcellsurvival[36].Ofinterest,Cdx2promotesanchorage-
independent growth through the transcriptional repression of
IGFBP-3 [37]. Thus, a tumor-promoting role of Cdx2 in colon
cancercanbeenvisaged.Takentogether,itcanbepostulatedthatthe
roleofCdx2inthe regulationofcoloncancermay dependuponthe
differentiation status of the colon cancer cells and interaction with
other transcription factors.
Findings from multiple studies have unveiled existence of a
complex interaction among Cdx1, Cdx2, GATA4 and HNF-1a in
the induction of intestinal gene expression including claudin family
member, claudin-2 [40,41]. It is important to note that similar to
claudin-1, claudin-2 expression is also upregulated in colon
carcinogenesis [42]. Cdx2 has been demonstrated to play role in
the regulation of other cell-cell adhesion proteins including LI-
cadherin, claudin-3 and claudin-4 [20]. In our current study, we
have identified consensus Cdx-binding site as well as GATA-
binding site in the human claudin-1 promoter. The fact that forced
expression of Cdx1, Cdx2 or GATA4 induced not only claudin-1
protein and mRNA expression but also induced luciferase-reporter
activity dependent upon the full-length human claudin-1 promoter
(21160 to +160) supports a causal role of above transcription
factors in the regulation of claudin-1 expression. Notably, deletion
of the claudin-1 promoter sequence from 21160 to 2840 bp
(310 bp deletion) of the 59-flanking region containing the Cdx-
and GATA4 binding sites abrogated the increase in the luciferase
activity observed using the full-length promoter construct. Further,
our finding that the Cdx1, Cdx2 or GATA4-dependent induction
of claudin-1 promoter activity can be further enhanced when
above transcription factors were co-expressed supports a complex
inter-dependence among these transcription factors in the
regulation of claudin-1 expression. The fact that similar forced
expression of HNF-1a did not affect claudin-1 expression renders
specificity to our findings (Figure S2). Further, our finding that
similar overexpression of Cdx1, Cdx2 or GATA4 in the renal
epithelial and breast cancer cells had no apparent effect upon
claudin-1 expression suggest that this is not a universal mechanism
of claudin-1 expression and is rather colon specific. It is possible
that these factors may require other co-factors to be active, which
are present only in the colon cancer cells.
Our data further suggested that among the transcription factors
under investigation, Cdx2 is the most potent inducer of claudin-1
expression. Indeed, our studies using ChIP analysis demonstrated
a direct association of the Cdx2 with claudin-1 promoter and thus
suggested that claudin-1 is a direct target for Cdx2-dependent
transcriptional regulation. It is further noteworthy that observed
binding of Cdx2 with claudin-1 promoter was not dependent upon
Cdx2-transcription activation domain as deletion of the Cdx2 N-
terminus (Cdx2ND) had no effect upon the Cdx2 binding with
claudin-1 promoter. Interestingly, our studies demonstrated that
the carboxyl-terminus of Cdx2 is required for the association of
Cdx2 with claudin-1 promoter as ChIP analysis using a Cdx2 C-
Figure 4. Analysis of human claudin-1 promoter deletion constructs. A. The reporter constructs containing sequentially deleted 59- flanking
fragments of the 1.2 kb claudin-1(–1160/2260) were prepared and transfected into SW480 (B) and HCT116 (C) cells as described under
‘‘Experimental Procedures’’. The results are expressed as relative luciferase activity of three different experiments carried out in triplicate (mean 6
S.D.). Differences between two groups were analyzed by the two-tailed Student’s t-test and of more than two groups by one-way ANOVA with post-
hoc Bonferroni Multiple Comparison test.
doi:10.1371/journal.pone.0037174.g004
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the binding of Cdx2 to claudin-1 promoter that was induced upon
expression of full-length Cdx2. This finding is interesting as
previous studies have suggested that DNA binding domain of
Cdx2 spans from 180–244 amino acids, compared to its C-
terminal (244–311 amino acids) which appeared critical for the
Figure 5. A. Cdx2 deletion mutants. HD: homeodomain; A, B, C: conserved domains. B. Luciferase activity after co-transfection with Cdx2 wild-
type and truncation mutants. Deletion of the Cdx2 C-terminus (Cdx2CD) significantly (***p,0.001) reduced claudin-1 reporter activity. C. Western
blot analysis using anti-Flag antibody to check equivalent expression of Cdx2 truncation mutants in SW480 cells transiently transfected with Cdx2
truncation mutant expression vectors. b-actin was used as loading control. D. Cdx2 binding to the 59-flanking region of claudin-1 gene promoter
shown by ChIP assay. Formaldehyde cross-linked chromatin prepared from 5610
7 SW480 cells was incubated with antibodies to Cdx2 or with IgG
(negative control). Cross-linking of the immunoprecipitates was reversed and the DNA purified and analyzed using primers specific for either the
claudin-1 promoter region or for glyceraldehyde-3-phosphate dehydrogenase. Results show that the induction of claudin-1 promoter activity by
Cdx2 requires Cdx2-C-terminus domain.
doi:10.1371/journal.pone.0037174.g005
Figure 6. Wnt-signaling helps mediate Cdx, GATA-dependent claudin-1 gene expression. Claudin-1 promoter activity in SW480 (A) and
HCT 116 cells (B). Cells were transiently co-transfected with expression vector constructs for activated b-catenin (S33Y) along with Cdx1, Cdx2 or
GATA4 expression vectors. Claudin-1 promoter activity was abrogated upon co-transfection of dnTcf-4 with Cdx1, Cdx2 or GATA4 expression vectors
SW480 (C) and HCT116 (D) cells.
doi:10.1371/journal.pone.0037174.g006
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claudin-1 promoter activity in our current study. Taken together,
we speculate that the C-terminus of Cdx2 protein may directly/
indirectly help modulate Cdx2 binding to the DNA. Our data
regarding the importance of C-terminus in Cdx2-dependent
transcriptional regulation is well supported by a previous study
where deletion of the Cdx2 C-terminus (Cdx2CD) also reduced
sucrase isomaltase reporter activity by ,50% in colon cancer cells
[22]. However, further studies will be needed to clearly understand
the details of the mechanism underlying Cdx2 binding with
claudin-1 promoter and are currently underway in our laboratory.
We further documented a novel finding that the Cdx1, Cdx2
and/or GATA4-dependent increase in claudin-1 promoter activity
was completely abolished when Wnt-signaling was inhibited using
co-transfection of the dn-Tcf construct. Conversely, effects of
Cdx1, Cdx2 or GATA4 expression upon claudin-1 promoter was
further induced upon simultaneous activation of Wnt-signaling,
using expression of the activated b-catenin (S-33Y b-catenin)
Figure 7. Correlation between claudin-1 and Cdx2 expression in colon cancer samples. A. Correlation between claudin-1 and Cdx2
expressions in colon cancer. Data from custom colorectal cancer tissue arrays (tissue microarrays developed at Vanderbilt) that contain surgical
specimens from 50 primary and paired metastatic fresh-frozen human colorectal cancer samples are shown. A significant direct correlation between
claudin-1 and Cdx2 expression was observed (**P,0.01) using Yates’s chi square test. B. representative staining for claudin-1 (a) and Cdx2 (b)i n
colon cancer patient samples. Sections were counterstained with hematoxylin to determine the structural details.
doi:10.1371/journal.pone.0037174.g007
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between b-catenin/Tcf/Lef-1 and Cdx1, Cdx2 and/or GATA4 in
the regulation of claudin-1 mRNA transcription. Notably, Wnt-
signaling is known to regulate the expression as well as biological
actions of the homeodomain transcription factors [43–45]. A
recent study has also demonstrated that Cdx2 binds many of the
same cis-regulatory regions as Tcf-4 in the intestinal epithelial cells,
and the Tcf-4 and Cdx2 co-occupancy predicts intestinal gene
expression better than occupancy by either of the factor alone
[46]. Claudin-1 itself is a known target of Tcf/Lef-dependent
transcription regulation [6]. Taken together, we postulate that co-
occupancy by a Wnt-effector protein and a tissue-restricted
homeobox transcription factor may represent the means for a
tissue-specific response in the intestinal context, including
increased colonic claudin-1 expression. Further, a functional
crosstalk between tight junction and adherens junction constitu-
ents has been demonstrated [47,48]. Thus, it can be postulated
that the b-catenin-Lef/Tcf-dependent regulation of claudin-1 gene
expression is part of the signaling mechanism/s functionally
relevant to the oncogenic transformation. Such a notion gains
support by published findings from ours and other laboratories
that increased claudin-1 expression in human colon cancer cells
bears causal correlation with the APC mutation [5,6]. Taken
together, the co-existence of the binding sites for Lef/Tcf and
Cdx-proteins in claudin-1 promoter suggests an interacting
network of direct and indirect modulation of claudin gene
expression by homeodomain transcription factors along with
Wnt-signaling pathway.
In summary, our experimental outcome support a model in
which claudin-1 expression is governed by a complex interaction/
inter-dependence among Cdx1, Cdx2 and GATA4 and a
functional cross-talk with the Wnt/Tcf/Lef-1 activity in an organ
specific manner. Our data supporting a significant and parallel
correlation between claudin-1 and Cdx2 expression in colon
cancer patient samples highlights the importance of this regulatory
relationship in the regulation of colonic homeostasis. Further
studies are needed to understand how above described regulatory
mechanism functions in the normal colonic epithelial cells vs.
cancer cells. Irrespective, findings from our current studies
demonstrates a complex regulation of claudin-1 expression, which
is critically relevant to the barrier function of normal epithelial
cells and oncogenic potential of the colon cancer cells. We believe
that our studies may shed new light in a potential causal
association of claudin-1 in the regulation of colonic epithelial
differentiation and its deregulation during the neoplastic growth
and oncogenic transformation.
Materials and Methods
Plasmids and Reagents
The antibodies against claudin-1 and -4 were from Invitrogen
(San Francisco, CA, USA), and E-cadherin was from BD
Biosciences (San Jose, CA, USA). Anti-Cdx1 and Cdx2 polyclonal
antibodies were from cell signaling (Cell Signaling Technology,
Inc. Danvers, MA). Antibody against GATA4 and the horseradish
peroxidase-conjugated anti-rabbit and anti-goat antibodies were
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). The
human Cdx1, Cdx2, GATA4 expression vectors (pRC/CMV-
Cdx1, pRC/CMV-Cdx2, pCDNA3.1-GATA4 and pBJ5hHNF-
1a) and Cdx2 truncation mutants (Flag-CD, Flag-d15, Flag2/
d55-136, Flag-d50, Flag-d140-180) were generous gift from Dr.
John P. Lynch (University of Pennsylvania, Philadelphia, PA). The
activated b-catenin (constitutively active, CA) S33Y mutant and
dominant negative (dn)-TCF-4 expression plasmids were provided
by Dr. K.W. Kinzler (Johns Hopkins, Baltimore, MD) and Dr. H.
Clevers (Netherlands Institute for Developmental Biology, Upsa-
lalaan, Utrecht, the Netherlands) respectively. The claudin-1
luciferase reporter plasmid is described previously [21].
Cell Culture and Transfection
The human colon cancer cell lines HCT116 and SW480 cells
were obtained from ATCC and cultured in RPMI 1640
containing 10% FBS, 100 U/ml penicillin, and 100 mg/ml
streptomycin. The renal tubular epithelial cells, MDCK-II cells
and human breast cancer cells, MCF-7 were (from ATCC) grown
in Dulbecco’s modified Eagle’s medium:nutrient mix F12 (In-
vitrogen, Carlsbad, CA) containing 10% FBS, 100 U/ml penicil-
lin, and 100 mg/ml streptomycin. One day before transfection,
cells were seeded in 6-well cell culture plates to provide a final
density of 60–70% confluence. Cells were transfected using
Effectene Transfection Reagent (QIAGEN Inc. USA) as described
previously [21]. Forty hours after transfection, cells were harvested
and luciferase activity was measured using the dual-luciferase
reporter assay system (Promega, Madison, WI) and an Optocomp
II Luminometer (MGM Instruments, Inc., Hamden, CT).
Transfection efficiency was normalized to Renilla luciferase activity
of the phRL-TK (Promega) and the results are expressed as the
mean relative luciferase activity 6 S.D. (at least three independent
experiments). We calculated fold stimulation for each sample by
dividing the normalized luciferase activity by the value obtained
from the control transfection containing empty vector (pGL3-
basic).
RNA Isolation, Semiquantitative Reverse Transcription–
PCR and Real-time PCR
Total RNA isolation and reverse transcription–PCR was
performed using standard protocols as described earlier [5,21].
For real-time PCR, complementary DNA (cDNA) was synthesized
and PCR was carried out using SYBR PCR master kit (Applied
Biosystems Inc., Foster City, CA, USA). The sequences of the
claudin-1 primers are 5
9-TCACTCCCAGGAGGATGC-3
9 (For-
ward Primer) and 5
9-GGCAGATCCAGTGCAAAGTC-39 (Re-
verse Primer). PCR was carried out in triplicates for each gene
being validated.
Western Blot Analysis
Immunoblotting was done using antigen-specific antibody using
standard protocol, as described previously [5]. The signal was
visualized with horseradish peroxidase-conjugated secondary
antibodies using enhanced chemiluminescence (Amersham Bio-
sciences, Piscataway, NJ).
Chromatin Immunoprecipitation (ChIP) Assay
ChIP assay was done using EZ-ChIP assay kit, (Upstate,
Millipore, Billercia, MA, USA) as per manufacturer’s protocol. In
brief, precleared and sonicated chromatin from 5610
7 (formalde-
hyde-treated) SW480 cells was immunoprecipitated using anti-
Cdx2 antibody. Normal rabbit IgG served as antibody control.
The supernatant from the above reaction lacking the primary
antibody was saved as total input of chromatin and was processed
in the same way as the eluted immunoprecipitates, starting with
the cross-linking reversal step. After processing, immunoprecipi-
tated chromatin was amplified using human claudin-1-specific
sense (5
9-AAACCGGAGGGTGAGAGATAG-3
9) and antisense
primers (5
9-TCGCAGGTGAGGACATGTAA-3
9). GAPDH-spe-
cific primers served as negative controls. PCR products were
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buffer.
Statistical Analysis
Data is presented as means 6 SD. Statistical significance was
tested, when applicable, with the t-test (P#0.05 for significance)
and Bonferroni correction was applied for multiple testing.
Supporting Information
Figure S1 Cdx1, Cdx2 and GATA4–dependent regula-
tion of claudin-1 luciferase reporter. SW480 cells were
transiently transfected with a 3.2-kb claudin-1-luciferase reporter
plasmid along with Cdx1, Cdx2 and GATA4 expression vectors.
Empty vector pGL3-basic was used for control purposes.
Nonspecific plasmid DNA was used to maintain equal amounts
of DNA in all transfection samples. Results are expressed in fold-
activation of relative luciferase activity after normalization with
Renilla activity from 3 independent experiments, and the values are
expressed as means 6 SD.
(TIFF)
Figure S2 HNF-1a-dependent regulation of claudin-1
luciferase reporter. SW480 cells were transiently transfected
with a 1.2-kb claudin-1-luciferase reporter plasmid along with
HNF-1a expression vector. Empty pGL3-basic vector was used for
control purposes. Results are expressed in fold-activation of
relative luciferase activity after normalization with Renilla activity
from 3 independent experiments, and the values are expressed as
means 6 SD.
(TIFF)
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